Pdt Partners, LLC Medpace Holdings, Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 8,783 shares of MEDP stock, worth $2.96 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

8,783

Previous 17,017 48.39%

Holding current value

$2.96 Million

Previous $7.01 Million 58.2%

% of portfolio

0.29%

Previous 0.71%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$320.58 - $457.29 $2.64 Million - $3.77 Million	-8,234 Reduced 48.39%	8,783 $2.93 Million
Q2 2024 Aug 15, 2024	SELL	$372.0 - $424.34 $1.49 Million - $1.69 Million	-3,992 Reduced 19.0%	17,017 $7.01 Million
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $5,127 - $7,439	-18 Reduced 0.09%	21,009 $8.49 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $35,038 - $48,152	-154 Reduced 0.73%	21,027 $6.45 Million
Q3 2023 Nov 14, 2023	BUY	$233.98 - $281.67 $462,110 - $556,298	1,975 Added 10.28%	21,181 $5.13 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $1.33 Million - $1.71 Million	7,101 Added 58.66%	19,206 $4.61 Million
Q1 2023 May 15, 2023	BUY	$174.31 - $239.52 $922,274 - $1.27 Million	5,291 Added 77.65%	12,105 $2.28 Million
Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $1.32 Million - $1.95 Million	-8,625 Reduced 55.87%	6,814 $1.45 Million
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $1.03 Million - $1.3 Million	-7,101 Reduced 31.5%	15,439 $2.43 Million
Q2 2022 Aug 15, 2022	BUY	$130.2 - $168.03 $578,869 - $747,061	4,446 Added 24.57%	22,540 $3.37 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $456,743 - $704,865	-3,289 Reduced 15.38%	18,094 $2.96 Million
Q4 2021 Feb 14, 2022	SELL	$182.74 - $227.9 $1.19 Million - $1.48 Million	-6,510 Reduced 23.34%	21,383 $4.65 Million
Q3 2021 Nov 15, 2021	BUY	$170.18 - $198.21 $675,104 - $786,299	3,967 Added 16.58%	27,893 $5.28 Million
Q2 2021 Aug 16, 2021	SELL	$158.62 - $194.3 $773,431 - $947,406	-4,876 Reduced 16.93%	23,926 $4.23 Million
Q1 2021 May 17, 2021	SELL	$132.02 - $168.26 $2,112 - $2,692	-16 Reduced 0.06%	28,802 $4.73 Million
Q4 2020 Feb 16, 2021	SELL	$109.38 - $149.19 $1.5 Million - $2.04 Million	-13,688 Reduced 32.2%	28,818 $4.01 Million
Q3 2020 Nov 16, 2020	BUY	$92.95 - $130.61 $610,309 - $857,585	6,566 Added 18.27%	42,506 $4.75 Million
Q2 2020 Aug 14, 2020	SELL	$68.08 - $95.68 $507,876 - $713,772	-7,460 Reduced 17.19%	35,940 $3.34 Million
Q1 2020 May 15, 2020	BUY	$61.71 - $101.95 $2.68 Million - $4.42 Million	43,400 New	43,400 $3.19 Million
Q1 2019 May 15, 2019	SELL	$49.38 - $70.58 $2.32 Million - $3.32 Million	-47,017 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$46.97 - $63.98 $2.69 Million - $3.66 Million	-57,248 Reduced 54.91%	47,017 $2.49 Million
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $1.57 Million - $2.32 Million	36,365 Added 53.56%	104,265 $6.25 Million
Q2 2018 Aug 14, 2018	BUY	$34.03 - $45.46 $408,360 - $545,520	12,000 Added 21.47%	67,900 $2.92 Million
Q1 2018 May 15, 2018	BUY	$32.03 - $39.05 $1.79 Million - $2.18 Million	55,900 New	55,900 $1.95 Million

Others Institutions Holding MEDP

# of Institutions

619

Shares Held

24.9M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.5B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account